NEW YORK (360Dx) – Today's World Health Organization's prequalification of OraSure Technologies' HIV self-test could reinforce international demand that's already driving sales growth for the test, according to an investment analyst.    

"With prequalification in hand, we expect ordering for the HIV self-test to begin picking up from the many countries with whom OraSure has been in dialogue," Mark Massaro, an analyst at Canaccord Genuity investment bank, said in an interview.